文献速递心血管胸部CTMR

已知或疑似心脏结节病患者行延迟对比增强CT的可行性研究

Delayed contrast-enhanced computed tomography in patients with known or suspected cardiac sarcoidosis: A feasibility study.
PubMed 文献 · Eur Radiol · 2017-04-05

本研究纳入24例已知或疑似心脏结节病患者,评估延迟对比增强CT(DE-CT)在有或无植入设备患者中的诊断价值,并与晚期钆增强心脏磁共振(LGE-CMR)定量比较。结果显示DE-CT与LGE-CMR在评估高强化心肌范围上相关性良好,DE-CT诊断心脏结节病的敏感度为94%、特异度为33%。

要点

  • DE-CT视觉检测高强化心肌节段的观察者间一致性极好(有植入设备者κ=0.91,无植入设备者κ=0.94)。
  • DE-CT与LGE-CMR评估高强化心肌面积百分比在患者水平和节段水平均呈良好相关(r=0.96和r=0.83,p<0.001)。
  • DE-CT诊断心脏结节病的敏感度为94%、特异度为33%,可能尤其适用于有CMR禁忌证的患者。

核心结论

  • DE-CT所示高强化病灶范围与LGE-CMR结果一致性良好,DE-CT检测心脏结节病敏感度高,可能尤其适用于有CMR禁忌证的患者。

研究设计与样本

  • 可行性研究,纳入24例已知或疑似心脏结节病患者(平均年龄64±9岁,17例女性),行回顾性心电门控DE-CT(80 kV,基于知识的迭代模型重建);14例无植入设备患者另行LGE-CMR,10例有起搏器或植入式心律转复除颤器患者未行LGE-CMR。

关键影像表现/征象

  • DE-CT上高强化心肌的视觉检测在有植入设备患者和无植入设备患者中观察者间一致性均极好(κ=0.91和κ=0.94)。
  • DE-CT与LGE-CMR评估高强化心肌面积百分比在患者水平分析中r=0.96(p<0.001),在节段水平分析中r=0.83(p<0.001)。

诊断标准与关键数值

  • DE-CT高强化心肌的定量评估采用高于远程心肌均值5个标准差的阈值。
  • DE-CT诊断心脏结节病的敏感度为94%,特异度为33%。

临床应用与阅片要点

  • DE-CT可用于有植入设备的患者,并检测心脏结节病病灶,结果与心脏MRI相似。
  • DE-CT检测心脏结节病敏感度高,可能尤其适用于有心脏MRI禁忌证的患者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate the diagnostic value of delayed contrast-enhanced computed tomography (DE-CT) for cardiac sarcoidosis (CS) in patients with or without implantable devices, including a quantitative comparison with late gadolinium enhancement cardiac magnetic resonance (LGE-CMR).

METHODS: Twenty-four patients (mean age, 64 ± 9 years; 17 women) with known or suspected CS underwent retrospective electrocardiogram-gated DE-CT at 80 kV with knowledge-based iterative model reconstruction. Fourteen patients without implantable devices also underwent LGE-CMR, while ten with pacemakers or implantable cardioverter-defibrillators did not. The presence of hyperenhanced myocardium was assessed visually and quantitatively using a 5-standard deviation threshold above the mean of remote myocardium.

RESULTS: Inter-observer agreement for visual detection of hyperenhanced segments on DE-CT was excellent in patients with implantable devices and in those without (κ = 0.91 and κ = 0.94, respectively). Comparisons of the percent area of hyperenhanced myocardium between DE-CT and LGE-CMR on both per-patient and per-segment analyses showed good correlations (r = 0.96 and r = 0.83, respectively; p < 0.001). The sensitivity and specificity of DE-CT for the diagnosis of CS were 94% and 33%.

CONCLUSIONS: The extent of hyperenhanced lesion with DE-CT showed good agreement with LGE-CMR results. DE-CT showed high sensitivity for detecting CS and may be useful particularly in patients with contraindications to CMR.

KEY POINTS: • Delayed contrast-enhanced CT (DE-CT) can be applied to patients with implantable devices. • DE-CT can detect cardiac sarcoidosis (CS) lesions similarly to cardiac MRI. • DE-CT shows high sensitivity for detecting CS. • DE-CT may be useful particularly in patients with contraindications to cardiac MRI.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Aikawa T, Oyama-Manabe N, Naya M, et al. Delayed contrast-enhanced computed tomography in patients with known or suspected cardiac sarcoidosis: A feasibility study. Eur Radiol. 2017. PMID: 28382537. doi:10.1007/s00330-017-4824-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。